quinazolines has been researched along with 5-((1-(2,6-dichlorobenzyl)piperidin-4-yl)methoxy)quinazoline-2,4-diamine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feng, Z; Gibbs, RM; Jacques, V; Ko, CP; Li, DK; Lin, MY; Miao, W; Pellizzoni, L; Plasterer, HL; Rucki, AA; Rusche, JR; Sharma, S; Sumner, CJ; Van Meerbeke, JP; Wee, CD; Xia, B | 1 |
| Bail, S; Barlow, C; Cardona, H; DiDonato, CJ; Durens, M; Emery, C; Gogliotti, RG; Heier, CR; Jacques, V; Jarecki, J; Jorgensen, M; Kiledjian, M; Kuntz, N; Plasterer, HL; Rusche, J; Singh, J; Xia, B | 1 |
| Bail, S; Kiledjian, M; Plasterer, HL; Rusche, J; Zhou, M | 1 |
| Androphy, EJ; Calo, A; Cherry, JJ; Custer, SK; DiDonato, CJ; Du, S; Foley, TL; Gopalsamy, A; Gordo, SM; Gordon, W; Hosea, N; Jones, LH; Krizay, DK; LaRosa, G; Li, H; Mathur, S; Menard, CA; Patel, P; Potter, K; Ramos-Zayas, R; Reedich, EJ; Rietz, A; Rong, H; Tones, MA; Zhang, B | 1 |
| Akashi, K; Al-Raqad, M; Arai, F; Bauer, DE; Buonamici, S; Canver, MC; Cole, MA; Ishikawa, Y; Macias-Trevino, C; Maeda, M; Maeda, T; Masuda, T; Nakano, M; Orkin, SH; Pinello, L; Reversade, B; Schoonenberg, VAC; Seiler, M; Semba, Y; Shboul, M; Yamauchi, T; Yao, Q | 1 |
5 other study(ies) available for quinazolines and 5-((1-(2,6-dichlorobenzyl)piperidin-4-yl)methoxy)quinazoline-2,4-diamine
| Article | Year |
|---|---|
The DcpS inhibitor RG3039 improves motor function in SMA mice.
Topics: Animals; Central Nervous System; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endoribonucleases; Humans; Mice; Mice, Transgenic; Motor Neurons; Muscles; Muscular Atrophy, Spinal; Neuromuscular Junction; Quinazolines; Ribonucleoproteins, Small Nuclear; Survival of Motor Neuron 1 Protein; Survival of Motor Neuron 2 Protein; Synaptic Transmission | 2013 |
The DcpS inhibitor RG3039 improves survival, function and motor unit pathologies in two SMA mouse models.
Topics: Administration, Oral; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Endoribonucleases; Female; Humans; Mice; Mice, Transgenic; Motor Neurons; Muscular Atrophy, Spinal; Quinazolines; Survival of Motor Neuron 2 Protein; Synapses | 2013 |
DcpS is a transcript-specific modulator of RNA in mammalian cells.
Topics: Base Sequence; Cell Line; DNA Primers; Endoribonucleases; Humans; Quinazolines; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Polymerase Chain Reaction; RNA Stability; RNA, Messenger; RNA, Untranslated | 2015 |
In vitro and in vivo effects of 2,4 diaminoquinazoline inhibitors of the decapping scavenger enzyme DcpS: Context-specific modulation of SMN transcript levels.
Topics: Animals; Cell Line; Disease Models, Animal; Endoribonucleases; Enzyme Inhibitors; Female; Gene Knockdown Techniques; HEK293 Cells; Humans; Male; Mice; Mice, Knockout; Muscular Atrophy, Spinal; Promoter Regions, Genetic; Quinazolines; RNA, Messenger; Survival of Motor Neuron 2 Protein | 2017 |
Genome-wide CRISPR-Cas9 Screen Identifies Leukemia-Specific Dependence on a Pre-mRNA Metabolic Pathway Regulated by DCPS.
Topics: Animals; Cell Line; CRISPR-Cas Systems; Endoribonucleases; Humans; Leukemia; Male; Metabolic Networks and Pathways; Mice, Inbred C57BL; Muscular Atrophy, Spinal; Quinazolines; RNA Precursors; RNA Splicing; RNA, Messenger | 2018 |